Trial Profile
A Phase 3, Randomized, Open Label, Safety and Efficacy Study of the Oral Factor Xa Inhibitor DU-176b Compared With Enoxaparin Sodium for Prevention of Venous Thromboembolism in Patients After Hip Fracture Surgery (STARS J-4 Trial).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Jun 2016
Price :
$35
*
At a glance
- Drugs Edoxaban (Primary) ; Enoxaparin sodium
- Indications Thromboembolism
- Focus Adverse reactions
- Acronyms STARS-J-4
- Sponsors Daiichi Sankyo Company
- 02 Sep 2010 New trial record